X

Trial Profile

Effect of Pitavastatin on Coronary Fibrous-cap Thickness - Assessment by Fourier-Domain Optical Coherence Tomography (ESCORT).

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 03 Nov 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pitavastatin (Primary)
Indications Acute coronary syndromes
Focus Pharmacodynamics
Acronyms ESCORT

Most Recent Events

30 Aug 2017 Primary endpoint (Percent change in coronary fibrous-cap thickness) has been met as presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
30 Aug 2017 Status changed from active, no longer recruiting to completed as presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
30 Aug 2017 Results assessing effects of early statin therapy on fibrous cap thickness, presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com